Procyrion

Procyrion is a medical device company based in Houston, Texas, that is developing a novel treatment for patients with heart failure. The company's flagship product, Aortix™, is a catheter-deployed circulatory assist device designed to be minimally invasive. It is specifically targeted at the significant portion of heart failure patients who are no longer responsive to medical therapy.

The Aortix™ device is a small, powerful pump mounted on a self-expanding anchor. It is placed in the descending thoracic aorta via a catheter, a procedure that can be performed in a catheterization laboratory. Once in place, the device works by reducing the afterload on the heart, which is the resistance the heart must overcome to pump blood. This allows the heart to rest and heal, while simultaneously improving blood flow to vital organs like the kidneys.

The company is focused on addressing the unmet needs of a large and growing patient population. Heart failure is a chronic and progressive disease that affects millions of people worldwide. Procyrion's technology has the potential to provide a new treatment option for these patients, improving their quality of life and reducing the high costs associated with their care. The company is currently in the clinical trial phase, gathering data to support the safety and efficacy of its device.

Keywords: medical device, cardiology, heart failure, circulatory support, catheter-based, renal impairment, Aortix, minimally invasive, afterload reduction, clinical trials